• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Two medical experts debate HPV vaccination

Two medical experts debate HPV vaccination

December 10, 2011 By Norma Leave a Comment

Guest Editorial in The Daily Iowan

Harper: Gather information and make your own choice

HPV Vaccines

Direct communication and full information are necessary to make health-related decisions.

As a physician who routinely treats women and men with HPV-diseases, my experience includes having sat at the bedside of women dying of cervical cancer; having performed tens of thousands of colposcopies; having surgically treated pre-invasive HPV-related disease; having been actively involved in HPV cancer-prevention research for more than 20 years at the National Cancer Institute, Dartmouth, and University of Missouri-Kansas City; having served as the state director for the CDC Breast and Cervical Cancer Early Detection Programs; having served as a consultant to both Merck (which manufactures the HPV vaccine Gardasil, the one used by University of Iowa Hospitals and Clinics) and GSK (which manufactures the HPV vaccine Cervarix) on the vaccine trial designs as well as the phase-II and phase-III trials for FDA approval of both Gardasil and Cervarix; having served as a consultant to the World Health Organization; and having been an invited visiting professor to more than 70 countries about cervical cancer-prevention and HPV-associated diseases. So it’s refreshing to see an editorial (“Recommend Pap smears, not vaccines” Nov. 29 The Daily Iowan) that does not shame or fear people into being vaccinated with Gardasil.

The current Pap-screening program in the United States has resulted in an average incidence of 8 per 100,000 cases of cervical cancer per annum. Black and Latina women have higher rates at 11.1 per 100,000 and 12.8 per 100,000. The very best that Pap screening can do is to reduce the incidence of cervical cancer to 2 to 3 per 100,000 women because of false-negative testing.

Ignoring Pap screening and making generous assumptions that Gardasil will last your whole life (for which there is no proof, only speculation), that the efficacy will remain at 100 percent for your whole life (again no proof, only speculation), that Gardasil will provide complete protection from HPV-16 and -18 and partial protection from HPV-31, and that every single female receives three doses on time, the lowest incidence of cervical cancer that Gardasil can achieve is 14 per 100,000 after 60 years of Gardasil use.

Making similar assumptions about Cervarix, but with the difference being protection against six of the cancer causing HPV types, the lowest incidence Cervarix can achieve is 9.35 per 100,000. Making similar assumptions about the monovalent Gardasil+5 vaccine that is being tested on women at the UI, the lowest incidence of cervical cancer achievable is 9.3 per 100,000 women.

Clearly, if one has to choose between Pap screening and vaccination, Pap screening is the way to detect early lesions so that these lesions caused by all 15 of the cancer causing HPV types can be treated and thus, cervical cancer prevented. Clearly, there is also a choice in which vaccine a woman may want if she chooses to add vaccination to her Pap screening program.

Read the entire article here.

Related

Filed Under: HPV Tagged With: experts debate, HPV VACCINES

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Kells student’s seizures after HPV vaccine

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

hpv autoimmune disorder

HPV Vaccine Side Effect Causes Autoimmune Disorder

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...